Aardvark Therapeutics, Inc.
AARD
$13.94
$0.382.80%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -16.32M | -14.37M | -9.31M | -8.78M | -4.18M |
| Total Depreciation and Amortization | 10.00K | 11.00K | 5.00K | -121.00K | 8.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.18M | 127.00K | 274.00K | 358.00K | 315.00K |
| Change in Net Operating Assets | -999.00K | 4.39M | -2.36M | 815.00K | -96.00K |
| Cash from Operations | -16.13M | -9.84M | -11.39M | -7.73M | -3.96M |
| Capital Expenditure | -4.00K | -91.00K | -- | -6.00K | -5.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 29.25M | 9.50M | -112.62M | -11.89M | -- |
| Cash from Investing | 29.25M | 9.41M | -112.62M | -11.90M | -5.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 171.00K | 6.00K | 91.19M | 163.00K | 169.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | 0.00 | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -77.00K | -2.31M | -1.18M | -105.00K |
| Cash from Financing | 171.00K | -71.00K | 88.88M | -1.01M | 64.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 13.29M | -506.00K | -35.14M | -20.64M | -3.90M |